Bayer operates in the life sciences with leading positions in pharmaceuticals and agricultural solutions. The pharmaceuticals business develops and commercializes prescription drugs in therapeutic areas including cardiology, oncology and women's health in addition to over-the-counter consumer products. Crop Science provides seeds, crop protection products, biologicals and digital agriculture tools that enable farmers to improve productivity and sustainability on a global scale.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 10,739 | — | -199 | — |
| Q3 2025 | 9,660 | — | -963 | — |
| Q4 2025 | 11,438 | — | -3,757 | — |
| Q1 2026 | 13,405 | — | 2,763 | — |
| Q2 2026 | 10,872 | 1.2% | 219 | — |
All markets — KeepWinning global stock screener
Other companies on DAX: BASF (BAS), E.ON (EOAN), RWE (RWE), Mercedes-Benz Group (MBG), Commerzbank (CBK), Siemens Healthineers (SHL)